<!-- wp:paragraph -->
<p>A&nbsp;<strong>COVID‑19 vaccine</strong>&nbsp;is a&nbsp;<a href="https://en.wikipedia.org/wiki/Vaccine">vaccine</a>&nbsp;intended to provide&nbsp;<a href="https://en.wikipedia.org/wiki/Acquired_immunity">acquired immunity</a>&nbsp;against&nbsp;<a href="https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2">severe acute respiratory syndrome coronavirus 2</a>&nbsp;(SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (<a href="https://en.wikipedia.org/wiki/COVID%E2%80%9119">COVID‑19</a>).</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Prior to the&nbsp;<a href="https://en.wikipedia.org/wiki/COVID%E2%80%9119_pandemic">COVID‑19 pandemic</a>, an established body of knowledge existed about the structure and function of&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus">coronaviruses</a>&nbsp;causing diseases like&nbsp;<a href="https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome">severe acute respiratory syndrome</a>&nbsp;(SARS) and&nbsp;<a href="https://en.wikipedia.org/wiki/Middle_East_respiratory_syndrome">Middle East respiratory syndrome</a>&nbsp;(MERS). This knowledge accelerated the development of various&nbsp;<a href="https://en.wikipedia.org/wiki/Vaccine_platform">vaccine platforms</a>&nbsp;during early 2020.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-pmid33341119-1">[1]</a></sup>&nbsp;The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-2">[2]</a></sup>&nbsp;In January 2020, the SARS-CoV-2&nbsp;<a href="https://en.wikipedia.org/wiki/DNA_sequencing">genetic sequence</a>&nbsp;data was shared through&nbsp;<a href="https://en.wikipedia.org/wiki/GISAID">GISAID</a>, and by March 2020, the global pharmaceutical industry announced a major commitment to address COVID‑19.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-3">[3]</a></sup>&nbsp;In 2020, the first COVID‑19 vaccines were developed and made available to the public through emergency authorizations<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:0-4">[4]</a></sup>&nbsp;and conditional approvals.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-5">[5]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-EU_PR_20201221-6">[6]</a></sup>&nbsp;Initially, most COVID‑19 vaccines were two-dose vaccines, with the sole exception being the single-dose&nbsp;<a href="https://en.wikipedia.org/wiki/Janssen_COVID-19_vaccine">Janssen COVID-19 vaccine</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:0-4">[4]</a></sup>&nbsp;However, immunity from the vaccines has been found to wane over time, requiring people to get&nbsp;<a href="https://en.wikipedia.org/wiki/Booster_dose">booster doses</a>&nbsp;of the vaccine to maintain immunity against COVID‑19.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:0-4">[4]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The COVID‑19 vaccines are widely credited for their role in reducing the spread of COVID‑19 and reducing the severity and death caused by COVID‑19.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:0-4">[4]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-7">[7]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-8">[8]</a></sup>&nbsp;According to a June 2022 study, COVID‑19 vaccines prevented an additional 14.4 to 19.8 million deaths in 185 countries and territories from 8 December 2020 to 8 December 2021.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-9">[9]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-10">[10]</a></sup>&nbsp;Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Beaumont-11">[11]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Common side effects of COVID‑19 vaccines include soreness, redness, rash, inflammation at the injection site, fatigue, headache,&nbsp;<a href="https://en.wikipedia.org/wiki/Myalgia">myalgia</a>&nbsp;(muscle pain), and&nbsp;<a href="https://en.wikipedia.org/wiki/Arthralgia">arthralgia</a>&nbsp;(joint pain), which resolve without medical treatment within a few days.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-who-back-12">[12]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:1-13">[13]</a></sup>&nbsp;COVID‑19 vaccines are not associated with a higher risk of adverse effects during pregnancy or while breastfeeding.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:2-14">[14]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:3-15">[15]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:9-16">[16]</a></sup>&nbsp;Serious&nbsp;<a href="https://en.wikipedia.org/wiki/Vaccine_adverse_event">adverse events</a>&nbsp;associated COVID‑19 vaccines, such as&nbsp;<a href="https://en.wikipedia.org/wiki/Allergy">allergic reactions</a>, are generally rare but of high interest to the public.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:0-4">[4]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:10-17">[17]</a></sup>&nbsp;Because COVID‑19 vaccines are relatively new, new claims about possible side effects are still being made, and sometimes reports conflict.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Slomski_2022-18">[18]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>As of 22&nbsp;September&nbsp;2022, 12.7&nbsp;billion doses of COVID‑19 vaccines have been administered worldwide based on official reports from&nbsp;<a href="https://en.wikipedia.org/wiki/List_of_national_public_health_agencies">national public health agencies</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Richie_2021-19">[19]</a></sup>&nbsp;By December 2020, more than 10 billion vaccine doses had been preordered by countries,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-mullard-20">[20]</a></sup>&nbsp;with about half of the doses purchased by&nbsp;<a href="https://en.wikipedia.org/wiki/World_Bank_high-income_economy">high-income countries</a>&nbsp;comprising 14% of the world's population.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-So-21">[21]</a></sup>&nbsp;Despite the extremely rapid development of effective&nbsp;<a href="https://en.wikipedia.org/wiki/MRNA_vaccine">mRNA</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector_vaccine">viral vector vaccines</a>, worldwide&nbsp;<a href="https://en.wikipedia.org/wiki/Vaccine_equity">vaccine equity</a>&nbsp;has not been achieved. The development and use of&nbsp;<a href="https://en.wikipedia.org/wiki/Whole_inactivated_virus">whole inactivated virus</a>&nbsp;(WIV) and protein-based vaccines have also been recommended, especially for use in&nbsp;<a href="https://en.wikipedia.org/wiki/Developing_countries">developing countries</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Hotez-22">[22]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Ye-23">[23]</a></sup>&nbsp;The United States&nbsp;<a href="https://en.wikipedia.org/wiki/Food_and_Drug_Administration">Food and Drug Administration</a>&nbsp;(FDA) has now authorized bivalent vaccines to protect against the original COVID-19 strain and its&nbsp;<a href="https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant">Omicron variant</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-24">[24]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2 id="mw-toc-heading">Contents</h2>
<!-- /wp:heading -->

<!-- wp:list -->
<ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Background">1Background</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Formulation">2Formulation</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Sequencing">3Sequencing</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Clinical_research">4Clinical research</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Post-vaccination_complications">4.1Post-vaccination complications</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Vaccine_types">5Vaccine types</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#mRNA_vaccines">5.1mRNA vaccines</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Adenovirus_vector_vaccines">5.2Adenovirus vector vaccines</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Inactivated_virus_vaccines">5.3Inactivated virus vaccines</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Subunit_vaccines">5.4Subunit vaccines</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Other_types">5.5Other types</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Vaccine_types_by_delivery_methods">5.6Vaccine types by delivery methods</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Planning_and_development">6Planning and development</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Challenges">6.1Challenges</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Organizations">6.2Organizations</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#History">6.3History</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Effectiveness">7Effectiveness</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Waning_effectiveness">7.1Waning effectiveness</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Adverse_events">8Adverse events</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Mix_and_match">9Mix and match</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Duration_of_immunity">10Duration of immunity</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Society_and_culture">11Society and culture</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Distribution">11.1Distribution</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Access">11.2Access</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Liability">11.3Liability</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Controversy">11.4Controversy</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Misinformation_and_hesitancy">11.5Misinformation and hesitancy</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#See_also">12See also</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Explanatory_notes">13Explanatory notes</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#References">14References</a></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Further_reading">15Further reading</a><ul><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Vaccine_protocols">15.1Vaccine protocols</a></li></ul></li><li><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#External_links">16External links</a></li></ul>
<!-- /wp:list -->

<!-- wp:heading -->
<h2>Background</h2>
<!-- /wp:heading -->

<!-- wp:list -->
<ul><li><a href="https://en.wikipedia.org/wiki/File:COVID-19_vaccine_doses_administered_by_continent.svg"></a>COVID‑19 vaccine doses administered by continent as of Oct 11, 2021. For vaccines that require multiple doses, each individual dose is counted. As the same person may receive more than one dose, the number of doses can be higher than the number of people in the population.</li><li><a href="https://en.wikipedia.org/wiki/File:World_map_of_share_of_people_who_received_all_doses_prescribed_by_the_initial_COVID-19_vaccination_protocol.png"></a>Map showing share of population fully vaccinated against COVID-19 relative to a country's total population<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-OWID-notes2-25">[note 1]</a></sup></li></ul>
<!-- /wp:list -->

<!-- wp:table -->
<figure class="wp-block-table"><table><tbody><tr><td>Part of&nbsp;<a href="https://en.wikipedia.org/wiki/Category:COVID-19_pandemic">a series</a>&nbsp;on the</td></tr><tr><th><a href="https://en.wikipedia.org/wiki/COVID-19_pandemic">COVID-19 pandemic</a></th></tr><tr><td><a href="https://en.wikipedia.org/wiki/File:Coronavirus._SARS-CoV-2.png"></a></td></tr><tr><td><a href="https://en.wikipedia.org/wiki/COVID-19">COVID-19</a>&nbsp;(disease)<a href="https://en.wikipedia.org/wiki/SARS-CoV-2">SARS-CoV-2</a>&nbsp;(virus)<a href="https://en.wikipedia.org/wiki/COVID-19_pandemic_cases">Cases</a><a href="https://en.wikipedia.org/wiki/COVID-19_pandemic_deaths">Deaths</a></td></tr><tr><td><a>show</a><a href="https://en.wikipedia.org/wiki/Timeline_of_the_COVID-19_pandemic">Timeline</a></td></tr><tr><td><a>show</a><a href="https://en.wikipedia.org/wiki/COVID-19_pandemic_by_country_and_territory">Locations</a></td></tr><tr><td><a>show</a>International response</td></tr><tr><td><a>hide</a>Medical response<a href="https://en.wikipedia.org/wiki/COVID-19_testing">Disease testing</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus_breathalyzer">Breathalyzer</a><a href="https://en.wikipedia.org/wiki/Development_of_COVID-19_tests">Development</a><a href="https://en.wikipedia.org/wiki/COVID-19_drug_development">Drug development</a><a href="https://en.wikipedia.org/wiki/COVID-19_drug_repurposing_research">Drug repurposing</a><a href="https://en.wikipedia.org/wiki/Public_health_mitigation_of_COVID-19">Public health mitigation</a><a>Vaccines</a><a href="https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_development">History</a><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_clinical_research">Research</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Embolic_and_thrombotic_events_after_COVID-19_vaccination">VITT</a><a href="https://en.wikipedia.org/wiki/Deployment_of_COVID-19_vaccines">Deployment</a><a href="https://en.wikipedia.org/wiki/List_of_COVID-19_vaccine_authorizations">Authorizations</a><a href="https://en.wikipedia.org/wiki/Operation_Warp_Speed">Operation Warp Speed</a><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_misinformation_and_hesitancy">Misinformation and hesitancy</a>&nbsp;<a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_hesitancy_in_the_United_States">US</a><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_card">Vaccine card</a><a href="https://en.wikipedia.org/wiki/Vaccine_passports_during_the_COVID-19_pandemic">Vaccine passports</a>Current vaccines<a href="https://en.wikipedia.org/wiki/CoronaVac">CoronaVac</a><a href="https://en.wikipedia.org/wiki/Covaxin">Covaxin</a><a href="https://en.wikipedia.org/wiki/Convidecia">Convidecia</a><a href="https://en.wikipedia.org/wiki/Janssen_COVID-19_vaccine">Janssen</a><a href="https://en.wikipedia.org/wiki/MVC_COVID-19_vaccine">Medigen</a><a href="https://en.wikipedia.org/wiki/Moderna_COVID-19_vaccine">Moderna</a><a href="https://en.wikipedia.org/wiki/Novavax_COVID-19_vaccine">Novavax</a><a href="https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine">Oxford–AstraZeneca</a><a href="https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine">Pfizer–BioNTech</a><a href="https://en.wikipedia.org/wiki/Sinopharm_BIBP_COVID-19_vaccine">Sinopharm BIBP</a><a href="https://en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine">Sputnik V</a></td></tr><tr><td><a>show</a><a href="https://en.wikipedia.org/wiki/Variants_of_SARS-CoV-2">Variants</a></td></tr><tr><td><a>show</a><a href="https://en.wikipedia.org/wiki/Economic_impact_of_the_COVID-19_pandemic">Economic impact</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/COVID-19_recession">recession</a></td></tr><tr><td><a>show</a><a href="https://en.wikipedia.org/wiki/Impact_of_the_COVID-19_pandemic">Impacts</a></td></tr><tr><td><a href="https://en.wikipedia.org/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg"></a>&nbsp;<a href="https://en.wikipedia.org/wiki/Portal:COVID-19">COVID-19 portal</a></td></tr><tr><td><a href="https://en.wikipedia.org/wiki/Template:COVID-19_pandemic_sidebar"><abbr title="View this template">v</abbr></a><a href="https://en.wikipedia.org/wiki/Template_talk:COVID-19_pandemic_sidebar"><abbr title="Discuss this template">t</abbr></a><a href="https://en.wikipedia.org/w/index.php?title=Template:COVID-19_pandemic_sidebar&amp;action=edit"><abbr title="Edit this template">e</abbr></a></td></tr></tbody></table></figure>
<!-- /wp:table -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:COVID_Vaccine_(50745583447).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:COVID_Vaccine_(50745583447).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>A US&nbsp;<a href="https://en.wikipedia.org/wiki/Airman">airman</a>&nbsp;receiving a COVID‑19 vaccine, December 2020</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Prior to COVID‑19, a vaccine for an infectious disease had never been produced in less than several years&nbsp;– and no vaccine existed for preventing a&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus">coronavirus</a>&nbsp;infection in humans.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-gates2-26">[25]</a></sup>&nbsp;However, vaccines have been produced against several animal diseases caused by coronaviruses, including (as of 2003)&nbsp;<a href="https://en.wikipedia.org/wiki/Infectious_bronchitis_virus">infectious bronchitis virus</a>&nbsp;in birds,&nbsp;<a href="https://en.wikipedia.org/wiki/Canine_coronavirus">canine coronavirus</a>, and&nbsp;<a href="https://en.wikipedia.org/wiki/Feline_coronavirus">feline coronavirus</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-27">[26]</a></sup>&nbsp;Previous projects to develop vaccines for viruses in the family&nbsp;<em><a href="https://en.wikipedia.org/wiki/Coronaviridae">Coronaviridae</a></em>&nbsp;that affect humans have been aimed at&nbsp;<a href="https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome">severe acute respiratory syndrome</a>&nbsp;(SARS) and&nbsp;<a href="https://en.wikipedia.org/wiki/Middle_East_respiratory_syndrome">Middle East respiratory syndrome</a>&nbsp;(MERS). Vaccines against SARS<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-28">[27]</a></sup>&nbsp;and MERS<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-29">[28]</a></sup>&nbsp;have been tested in non-human&nbsp;<a href="https://en.wikipedia.org/wiki/Model_organism">animals</a>.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and&nbsp;<a href="https://en.wikipedia.org/wiki/List_of_national_public_health_agencies">public health agencies</a>&nbsp;around the world at that time.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-PMID_15655773-30">[29]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-PMID_15885812-31">[30]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-PMID_16453264-32">[31]</a></sup>&nbsp;There is no cure or protective vaccine proven to be safe and effective against SARS in humans.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-JiangFutureVirology-33">[32]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-34">[33]</a></sup>&nbsp;There is also no proven vaccine against MERS.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-35">[34]</a></sup>&nbsp;When MERS became prevalent, it was believed that existing SARS research might provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-JiangFutureVirology-33">[32]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Butler3oct2013-36">[35]</a></sup>&nbsp;As of March 2020, there was one (DNA-based) MERS vaccine which completed Phase&nbsp;I clinical trials in humans,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-37">[36]</a></sup>&nbsp;and three others in progress, all being viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) and one&nbsp;<a href="https://en.wikipedia.org/wiki/Modified_vaccinia_Ankara">MVA</a>-vectored (MVA-MERS-S).<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-38">[37]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Vaccines that use an inactive or weakened virus that has been grown in eggs typically take more than a decade to develop.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Moderna_and_Pfizer_Are_Reinventing_Vaccines-39">[38]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-40">[39]</a></sup>&nbsp;In contrast, mRNA is a molecule that can be made quickly, and research on mRNA to fight diseases was begun decades before the COVID‑19 pandemic by scientists such as&nbsp;<a href="https://en.wikipedia.org/wiki/Drew_Weissman">Drew Weissman</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Katalin_Karik%C3%B3">Katalin Karikó</a>, who tested on mice.&nbsp;<a href="https://en.wikipedia.org/wiki/Moderna">Moderna</a>&nbsp;began human testing of an&nbsp;<a href="https://en.wikipedia.org/wiki/MRNA_vaccine">mRNA vaccine</a>&nbsp;in 2015.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Moderna_and_Pfizer_Are_Reinventing_Vaccines-39">[38]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector_vaccine">Viral vector vaccines</a>&nbsp;were also developed for the COVID‑19 pandemic after the technology was previously cleared for Ebola.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Moderna_and_Pfizer_Are_Reinventing_Vaccines-39">[38]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>As multiple COVID‑19 vaccines have been authorized or licensed for use, real-world vaccine effectiveness (RWE) is being assessed using case control and observational studies.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-41">[40]</a></sup>&nbsp;A study is investigating the long-lasting protection against SARS-CoV-2 provided by the mRNA vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-42">[41]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-43">[42]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2>Formulation</h2>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>As of September&nbsp;2020, eleven of the vaccine candidates in clinical development use&nbsp;<a href="https://en.wikipedia.org/wiki/Adjuvants">adjuvants</a>&nbsp;to enhance immunogenicity.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup>&nbsp;An&nbsp;<a href="https://en.wikipedia.org/wiki/Immunological_adjuvant">immunological adjuvant</a>&nbsp;is a substance formulated with a vaccine to elevate the immune response to an&nbsp;<a href="https://en.wikipedia.org/wiki/Antigen">antigen</a>, such as the COVID‑19 virus or influenza virus.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-tregoning-45">[44]</a></sup>&nbsp;Specifically, an adjuvant may be used in formulating a COVID‑19 vaccine candidate to boost its immunogenicity and efficacy to reduce or prevent COVID‑19 infection in vaccinated individuals.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-tregoning-45">[44]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-wang-46">[45]</a></sup>&nbsp;Adjuvants used in COVID‑19 vaccine formulation may be particularly effective for technologies using the inactivated COVID‑19 virus and recombinant protein-based or vector-based vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-wang-46">[45]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/Aluminium">Aluminum salts</a>, known as "alum", were the first adjuvant used for licensed vaccines, and are the adjuvant of choice in some 80% of adjuvanted vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-wang-46">[45]</a></sup>&nbsp;The alum adjuvant initiates diverse molecular and cellular mechanisms to enhance immunogenicity, including release of proinflammatory cytokines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-tregoning-45">[44]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-wang-46">[45]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2>Sequencing</h2>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>In November 2021, the full nucleotide sequences of the AstraZeneca and Pfizer/BioNTech vaccines were released by the UK&nbsp;<a href="https://en.wikipedia.org/wiki/Medicines_and_Healthcare_products_Regulatory_Agency">Medicines and Healthcare products Regulatory Agency</a>, in response to a&nbsp;<a href="https://en.wikipedia.org/wiki/Freedom_of_Information_Act_2000">freedom of information</a>&nbsp;request.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-47">[46]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Taylor-48">[47]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2>Clinical research</h2>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_clinical_research">COVID-19 vaccine clinical research</a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine_clinical_research">COVID-19 vaccine clinical research</a>&nbsp;uses&nbsp;<a href="https://en.wikipedia.org/wiki/Clinical_research">clinical research</a>&nbsp;to establish the characteristics of COVID-19 vaccines. These characteristics include&nbsp;<a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Efficacy">efficacy</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#Effectiveness">effectiveness</a>&nbsp;and safety. As of August&nbsp;2022, forty vaccines are authorized by at least one national&nbsp;<a href="https://en.wikipedia.org/wiki/Regulation_of_therapeutic_goods">regulatory authority</a>&nbsp;for public use:<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-COVID-19_vaccine_clinical_research_london2-49">[48]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-50">[49]</a></sup>As of June&nbsp;2022, 353 vaccine candidates are in various stages of development, with 135 in&nbsp;<a href="https://en.wikipedia.org/wiki/Clinical_research">clinical research</a>, including 38 in&nbsp;<a href="https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_I">phase&nbsp;I trials</a>, 32 in&nbsp;<a href="https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_II">phase&nbsp;I–II trials</a>, 39 in&nbsp;<a href="https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_III">phase&nbsp;III trials</a>, and 9 in&nbsp;<a href="https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_IV">phase&nbsp;IV development</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-COVID-19_vaccine_clinical_research_london2-49">[48]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>Post-vaccination complications</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/Embolic_and_thrombotic_events_after_COVID-19_vaccination">Embolic and thrombotic events after COVID-19 vaccination</a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Post-vaccination embolic and thrombotic events, termed&nbsp;<a href="https://en.wikipedia.org/wiki/Embolic_and_thrombotic_events_after_COVID-19_vaccination">vaccine-induced immune thrombotic thrombocytopenia</a>&nbsp;(VITT),<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_GreinacherNEJM-51">[50]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_Cines-2021.Apr.16-52">[51]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-53">[52]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:1-54">[53]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:0-55">[54]</a></sup>&nbsp;vaccine-induced prothrombotic immune thrombocytopenia (VIPIT),<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_PHA-Canada_March-56">[55]</a></sup>&nbsp;thrombosis with thrombocytopenia syndrome (TTS),<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_LongBridwell2021-57">[56]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:1-54">[53]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:0-55">[54]</a></sup>&nbsp;vaccine-induced immune thrombocytopenia and thrombosis (VITT),<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:0-55">[54]</a></sup>&nbsp;or vaccine-associated thrombotic thrombocytopenia (VATT),<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_:0-55">[54]</a></sup>&nbsp;are rare types of&nbsp;<a href="https://en.wikipedia.org/wiki/Thrombosis">blood clotting</a>&nbsp;syndromes that were initially observed in a number of people who had previously received the&nbsp;<a href="https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID%E2%80%9119_vaccine">Oxford–AstraZeneca COVID‑19 vaccine</a>&nbsp;(AZD1222)<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-62">[a]</a></sup>&nbsp;during the&nbsp;<a href="https://en.wikipedia.org/wiki/COVID%E2%80%9119_pandemic">COVID‑19 pandemic</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_PHA-Canada_March-56">[55]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_ema28mar-63">[61]</a></sup>&nbsp;It was subsequently also described in the&nbsp;<a href="https://en.wikipedia.org/wiki/Janssen_COVID%E2%80%9119_vaccine">Janssen COVID‑19 vaccine</a>&nbsp;(Johnson &amp; Johnson) leading to suspension of its use until its safety had been reassessed.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-64">[62]</a></sup>&nbsp;On 5 May 2022 the FDA posted a bulletin limiting the use of the Janssen Vaccine to very specific cases due to further reassesment of the risks of TTS, although the FDA also stated in the same bulletin that the benefits of the vaccine outweigh the risks.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_FDA_Limits_Use_of_Janssen_COVID-19_Vaccine-65">[63]</a></sup>In April 2021,&nbsp;<a href="https://en.wikipedia.org/wiki/AstraZeneca">AstraZeneca</a>&nbsp;and the&nbsp;<a href="https://en.wikipedia.org/wiki/European_Medicines_Agency">European Medicines Agency</a>&nbsp;(EMA) updated their information for healthcare professionals about AZD1222, saying it is "considered plausible" that there is a causal relationship between the vaccination and the occurrence of thrombosis in combination with thrombocytopenia and that, "although such adverse reactions are very rare, they exceeded what would be expected in the general population".<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_ema28mar-63">[61]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_ema13apr-66">[64]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Embolic_and_thrombotic_events_after_COVID-19_vaccination_MHRA-20210401-67">[65]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-FOOTNOTEEMA2021-68">[66]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2>Vaccine types</h2>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:Vaccine_candidate_mechanisms_for_SARS-CoV-2_(49948301838).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Conceptual diagram showing three vaccine types for forming SARS‑CoV‑2 proteins to prompt an immune response: (1)&nbsp;<a href="https://en.wikipedia.org/wiki/RNA_vaccine">RNA vaccine</a>, (2)&nbsp;<a href="https://en.wikipedia.org/wiki/Subunit_vaccine">subunit vaccine</a>, (3)&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector">viral vector</a>&nbsp;vaccine</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:Fimmu-11-579250-g004.jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:Fimmu-11-579250-g004.jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Vaccine platforms being employed for SARS-CoV-2. Whole virus vaccines include both&nbsp;<a href="https://en.wikipedia.org/wiki/Attenuated_vaccine">attenuated</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Inactivated_vaccine">inactivated</a>&nbsp;forms of the virus. Protein and&nbsp;<a href="https://en.wikipedia.org/wiki/Peptide_vaccine">peptide</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Subunit_vaccine">subunit</a>&nbsp;vaccines are usually combined with an&nbsp;<a href="https://en.wikipedia.org/wiki/Immunologic_adjuvant">adjuvant</a>&nbsp;in order to enhance immunogenicity. The main emphasis in SARS-CoV-2 vaccine development has been on using the whole&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus_spike_protein">spike protein</a>&nbsp;in its trimeric form, or components of it, such as the&nbsp;<a href="https://en.wikipedia.org/wiki/Binding_domain">RBD</a>&nbsp;region. Multiple non-replicating&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector_vaccine">viral vector vaccines</a>&nbsp;have been developed, particularly focused on&nbsp;<a href="https://en.wikipedia.org/wiki/Adenoviridae">adenovirus</a>, while there has been less emphasis on the replicating viral vector constructs.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-69">[67]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>As of July 2021, at least nine different technology platforms are under research and development to create an effective vaccine against COVID‑19.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-london-70">[68]</a></sup>&nbsp;Most of the platforms of vaccine candidates in clinical trials are focused on the&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus#Microbiology">coronavirus spike protein (S protein) and its variants</a>&nbsp;as the primary&nbsp;<a href="https://en.wikipedia.org/wiki/Antigen">antigen</a>&nbsp;of COVID‑19 infection,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup>&nbsp;since the S protein triggers strong B-cell and T-cell immune responses.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-71">[69]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Grifoni_2020-72">[70]</a></sup>&nbsp;However, other coronavirus proteins are also being investigated for vaccine development, like the&nbsp;<a href="https://en.wikipedia.org/wiki/Nucleocapsid">nucleocapsid</a>, because they also induce a robust T-cell response and their genes are more conserved and recombine less frequently (compared to Spike).<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Grifoni_2020-72">[70]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-73">[71]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-74">[72]</a></sup>&nbsp;Future generations of COVID-19 vaccines that may target more and conserved genomic regions will also act as an insurance against the manifestation of catastrophic scenarios concerning the future evolutionary path of SARS-CoV-2, or any similar Coronavirus epidemic/pandemic.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-75">[73]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Platforms developed in 2020 involved&nbsp;<a href="https://en.wikipedia.org/wiki/Nucleic_acid">nucleic acid</a>&nbsp;technologies (<a href="https://en.wikipedia.org/wiki/Nucleoside-modified_messenger_RNA">nucleoside-modified messenger RNA</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/DNA">DNA</a>), non-replicating&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector">viral vectors</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Peptide">peptides</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Recombinant_protein">recombinant proteins</a>, live&nbsp;<a href="https://en.wikipedia.org/wiki/Attenuated_virus">attenuated viruses</a>, and&nbsp;<a href="https://en.wikipedia.org/wiki/Virus_processing#Viral_inactivation">inactivated viruses</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-gates2-26">[25]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh-76">[74]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-diamond-77">[75]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Many vaccine technologies being developed for COVID‑19 are not like vaccines already in use to prevent&nbsp;<a href="https://en.wikipedia.org/wiki/Influenza">influenza</a>, but rather are using "next-generation" strategies for precise targeting of COVID‑19 infection mechanisms.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh-76">[74]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-diamond-77">[75]</a></sup>&nbsp;Several of the synthetic vaccines use a 2P mutation to lock the&nbsp;<a href="https://en.wikipedia.org/wiki/Coronavirus_spike_protein">spike protein</a>&nbsp;into its prefusion configuration, stimulating an&nbsp;<a href="https://en.wikipedia.org/wiki/Adaptive_immune_response">adaptive immune response</a>&nbsp;to the virus before it attaches to a human cell.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-78">[76]</a></sup>&nbsp;Vaccine platforms in development may improve flexibility for antigen manipulation, and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children,&nbsp;<a href="https://en.wikipedia.org/wiki/COVID%E2%80%9119_in_pregnancy">pregnant women</a>, and people with weakened&nbsp;<a href="https://en.wikipedia.org/wiki/Immune_system">immune systems</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh-76">[74]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>mRNA vaccines</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Further information:&nbsp;<a href="https://en.wikipedia.org/wiki/MRNA_vaccine">mRNA vaccine</a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:RNA_vaccine_illustration_(en).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/File:RNA_vaccine_illustration_(en).jpg"></a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Diagram of the operation of an&nbsp;<a href="https://en.wikipedia.org/wiki/RNA_vaccine">RNA vaccine</a>.&nbsp;<a href="https://en.wikipedia.org/wiki/Messenger_RNA">Messenger RNA</a>&nbsp;contained in the vaccine enters cells and is&nbsp;<a href="https://en.wikipedia.org/wiki/Translation_(biology)">translated</a>&nbsp;into foreign proteins, which trigger an immune response.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Several COVID‑19 vaccines, including the&nbsp;<a href="https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID%E2%80%9119_vaccine">Pfizer–BioNTech</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Moderna_COVID%E2%80%9119_vaccine">Moderna</a>&nbsp;vaccines, have been developed to use&nbsp;<a href="https://en.wikipedia.org/wiki/RNA">RNA</a>&nbsp;to stimulate an immune response. When introduced into human tissue, the vaccine contains either self-replicating RNA or&nbsp;<a href="https://en.wikipedia.org/wiki/Messenger_RNA">messenger RNA</a>&nbsp;(mRNA), which both cause cells to express the SARS-CoV-2 spike protein. This teaches the body how to identify and destroy the corresponding pathogen. RNA vaccines often, but not always, use&nbsp;<a href="https://en.wikipedia.org/wiki/Nucleoside-modified_messenger_RNA">nucleoside-modified messenger RNA</a>. The&nbsp;<a href="https://en.wikipedia.org/wiki/Drug_delivery">delivery</a>&nbsp;of mRNA is achieved by a coformulation of the molecule into&nbsp;<a href="https://en.wikipedia.org/wiki/Lipid_nanoparticle">lipid nanoparticles</a>&nbsp;which protect the RNA strands and help their absorption into the cells.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-79">[77]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-pmid33340620-80">[78]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Kowalski-81">[79]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Verbeke_2019-82">[80]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>RNA vaccines are the first COVID‑19 vaccines to be authorized in the United Kingdom, the United States and the European Union.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-83">[81]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-84">[82]</a></sup>&nbsp;Authorized vaccines of this type are the Pfizer–BioNTech<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-hcreg-85">[83]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04368728-86">[84]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-EudraCT-2020-001038-36-87">[85]</a></sup>&nbsp;and Moderna vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04470427-88">[86]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-palca-89">[87]</a></sup>&nbsp;The&nbsp;<a href="https://en.wikipedia.org/wiki/CVnCoV">CVnCoV</a>&nbsp;RNA vaccine from&nbsp;<a href="https://en.wikipedia.org/wiki/CureVac">CureVac</a>&nbsp;failed in clinical trials.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-90">[88]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Severe allergic reactions are rare. In December 2020, 1,893,360 first doses of Pfizer–BioNTech COVID‑19 vaccine administration resulted in 175 cases of severe allergic reaction, of which 21 were&nbsp;<a href="https://en.wikipedia.org/wiki/Anaphylaxis">anaphylaxis</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-pmid33571463-91">[89]</a></sup>&nbsp;For 4,041,396 Moderna COVID‑19 vaccine dose administrations in December 2020 and January 2021, only ten cases of anaphylaxis were reported.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-pmid33571463-91">[89]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/Solid_lipid_nanoparticle">Lipid nanoparticles</a>&nbsp;(LNPs) were most likely responsible for the allergic reactions.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-pmid33571463-91">[89]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>Adenovirus vector vaccines</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>These vaccines are examples of non-replicating&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector_vaccine">viral vector vaccines</a>, using an&nbsp;<a href="https://en.wikipedia.org/wiki/Adenoviridae">adenovirus</a>&nbsp;shell containing DNA that encodes a SARS‑CoV‑2 protein.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-vv-gavi-92">[90]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-93">[91]</a></sup>&nbsp;The viral vector-based vaccines against COVID‑19 are non-replicating, meaning that they do not make new virus particles, but rather produce only the antigen which elicits a systemic immune response.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-vv-gavi-92">[90]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Authorized&nbsp;<a href="https://en.wikipedia.org/wiki/Viral_vector#Vaccines">vaccines of this type</a>&nbsp;are the&nbsp;<a href="https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID%E2%80%9119_vaccine">Oxford–AstraZeneca COVID‑19 vaccine</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04400838-94">[92]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-EudraCT-2020-001228-32-95">[93]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-ISRCTN89951424-96">[94]</a></sup>&nbsp;the&nbsp;<a href="https://en.wikipedia.org/wiki/Sputnik_V_COVID%E2%80%9119_vaccine">Sputnik V COVID‑19 vaccine</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-sputnik-97">[95]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/Convidecia">Convidecia</a>, and the&nbsp;<a href="https://en.wikipedia.org/wiki/Janssen_COVID%E2%80%9119_vaccine">Janssen COVID‑19 vaccine</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04436276-98">[96]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04505722-99">[97]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/Convidecia">Convidecia</a>&nbsp;and the&nbsp;<a href="https://en.wikipedia.org/wiki/Janssen_COVID%E2%80%9119_vaccine">Janssen COVID‑19 vaccine</a>&nbsp;are both one-shot vaccines which offer less complicated logistics and can be stored under ordinary refrigeration for several months.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-100">[98]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-101">[99]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/Sputnik_V_COVID%E2%80%9119_vaccine">Sputnik V</a>&nbsp;uses Ad26 for its first dose, which is the same as&nbsp;<a href="https://en.wikipedia.org/wiki/Janssen_COVID%E2%80%9119_vaccine">Janssen</a>'s only dose, and Ad5 for the second dose, which is the same as&nbsp;<a href="https://en.wikipedia.org/wiki/Convidecia">Convidecia</a>'s only dose.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-102">[100]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>In August 2021, the&nbsp;<a href="https://en.wikipedia.org/wiki/Russian_Direct_Investment_Fund">developers of Sputnik V</a>&nbsp;proposed, in view of the Delta case surge, that Pfizer test the Ad26 component (termed its 'Light' version)<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-103">[101]</a></sup>&nbsp;as a booster shot:</p>
<!-- /wp:paragraph -->

<!-- wp:quote -->
<blockquote class="wp-block-quote"><p>Delta cases surge in US &amp; Israel shows mRNA vaccines need a heterogeneous booster to strengthen &amp; prolong immune response. #SputnikV pioneered mix&amp;match approach, combo trials &amp; showed 83.1% efficacy vs Delta. Today&nbsp;<a href="https://en.wikipedia.org/wiki/Russian_Direct_Investment_Fund">RDIF</a>&nbsp;offers Pfizer to start trial with Sputnik Light as booster.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-104">[102]</a></sup></p></blockquote>
<!-- /wp:quote -->

<!-- wp:heading {"level":3} -->
<h3>Inactivated virus vaccines</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/Inactivated_vaccine">Inactivated vaccines</a>&nbsp;consist of virus particles that are grown in&nbsp;<a href="https://en.wikipedia.org/wiki/Microbiological_culture">culture</a>&nbsp;and then killed using a method such as heat or&nbsp;<a href="https://en.wikipedia.org/wiki/Formaldehyde">formaldehyde</a>&nbsp;to lose disease producing capacity, while still stimulating an immune response.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-PetrovskyAguilar2004-105">[103]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Authorized vaccines of this type are the Chinese&nbsp;<a href="https://en.wikipedia.org/wiki/CoronaVac">CoronaVac</a><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04383574-106">[104]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCname=_nct04456595=-107">[105]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-PT_Bio_Farma-108">[106]</a></sup>&nbsp;and the Sinopharm&nbsp;<a href="https://en.wikipedia.org/wiki/Sinopharm_BIBP_COVID%E2%80%9119_vaccine">BIBP</a><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-ChiCTR2000034780-109">[107]</a></sup>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Sinopharm_WIBP_COVID%E2%80%9119_vaccine">WIBP</a>&nbsp;vaccines; the Indian&nbsp;<a href="https://en.wikipedia.org/wiki/BBV152">Covaxin</a>; later this year the Russian&nbsp;<a href="https://en.wikipedia.org/wiki/CoviVac_(Russia_COVID%E2%80%9119_vaccine)">CoviVac</a>;<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-110">[108]</a></sup>&nbsp;the&nbsp;<a href="https://en.wikipedia.org/wiki/Kazakhstan">Kazakh</a>&nbsp;vaccine&nbsp;<a href="https://en.wikipedia.org/wiki/QazVac">QazVac</a>;<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-111">[109]</a></sup>&nbsp;and the Iranian&nbsp;<a href="https://en.wikipedia.org/wiki/COVIran_Barekat">COVIran Barekat</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-112">[110]</a></sup>&nbsp;Vaccines in clinical trials include the&nbsp;<a href="https://en.wikipedia.org/wiki/VLA2001">Valneva COVID‑19 vaccine</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-precisionvaccinations-20201231-113">[111]</a></sup><sup>[<em><a href="https://en.wikipedia.org/wiki/Wikipedia:Reliable_sources">unreliable source?</a></em>]</sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-clinicaltrials-20201230-114">[112]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>Subunit vaccines</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p><a href="https://en.wikipedia.org/wiki/Subunit_vaccine">Subunit vaccines</a>&nbsp;present one or more&nbsp;<a href="https://en.wikipedia.org/wiki/Antigen">antigens</a>&nbsp;without introducing whole pathogen particles. The antigens involved are often&nbsp;<a href="https://en.wikipedia.org/wiki/Protein_subunit">protein subunits</a>, but can be any molecule that is a fragment of the pathogen.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-115">[113]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The authorized vaccines of this type are the&nbsp;<a href="https://en.wikipedia.org/wiki/Peptide_vaccine">peptide vaccine</a>&nbsp;<a href="https://en.wikipedia.org/wiki/EpiVacCorona">EpiVacCorona</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04527575-116">[114]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/ZF2001">ZF2001</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-london-70">[68]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/MVC_COVID%E2%80%9119_vaccine">MVC-COV1901</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-117">[115]</a></sup>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Corbevax">Corbevax</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-118">[116]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-119">[117]</a></sup>&nbsp;Vaccines with pending authorizations or include the&nbsp;<a href="https://en.wikipedia.org/wiki/Novavax_COVID%E2%80%9119_vaccine">Novavax COVID‑19 vaccine</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04368988-120">[118]</a></sup>&nbsp;<a href="https://en.wikipedia.org/wiki/Soberana_02">Soberana 02</a>&nbsp;(a&nbsp;<a href="https://en.wikipedia.org/wiki/Conjugate_vaccine">conjugate vaccine</a>), and the&nbsp;<a href="https://en.wikipedia.org/wiki/Sanofi%E2%80%93GSK_COVID%E2%80%9119_vaccine">Sanofi–GSK vaccine</a>.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The&nbsp;<a href="https://en.wikipedia.org/wiki/V451_vaccine">V451 vaccine</a>&nbsp;was previously in clinical trials, which were terminated because it was found that the vaccine may potentially cause incorrect results for subsequent HIV testing.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04495933-121">[119]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:7-122">[120]</a></sup><sup>[<em><a href="https://en.wikipedia.org/wiki/Wikipedia:Reliable_sources">unreliable source?</a></em>]</sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>Other types</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Additional types of vaccines that are in clinical trials include&nbsp;<a href="https://en.wikipedia.org/wiki/Virus-like_particle">virus-like particle</a>&nbsp;vaccines, multiple&nbsp;<a href="https://en.wikipedia.org/wiki/DNA_vaccine">DNA plasmid vaccines</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:4-123">[121]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04336410-124">[122]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:5-125">[123]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04463472-126">[124]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04445389-127">[125]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-gen-reut-128">[126]</a></sup>&nbsp;at least two&nbsp;<a href="https://en.wikipedia.org/wiki/Lentiviral_vector_in_gene_therapy">lentivirus vector</a>&nbsp;vaccines,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04299724-129">[127]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04276896-130">[128]</a></sup>&nbsp;a&nbsp;<a href="https://en.wikipedia.org/wiki/Conjugate_vaccine">conjugate vaccine</a>, and a&nbsp;<a href="https://en.wikipedia.org/wiki/Vesicular_stomatitis_virus">vesicular stomatitis virus</a>&nbsp;displaying the SARS‑CoV‑2 spike protein.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-NCT04608305-131">[129]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Scientists investigated whether existing vaccines for unrelated conditions could prime the immune system and lessen the severity of COVID‑19 infection.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-132">[130]</a></sup>&nbsp;There is experimental evidence that the&nbsp;<a href="https://en.wikipedia.org/wiki/BCG_vaccine">BCG vaccine</a>&nbsp;for tuberculosis has non-specific effects on the immune system, but no evidence that this vaccine is effective against COVID‑19.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-133">[131]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":3} -->
<h3>Vaccine types by delivery methods</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Currently, all coronavirus vaccines available, regardless of the different types of technology they are based on, are administrated by injection. However, various other types of vaccine delivery methods have been studied for future coronavirus vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-134">[132]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":4} -->
<h4>Intranasal</h4>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Intranasal vaccines target&nbsp;<a href="https://en.wikipedia.org/wiki/Mucosal_immunology">mucosal immunity</a>&nbsp;in the&nbsp;<a href="https://en.wikipedia.org/wiki/Nasal_mucosa">nasal mucosa</a>&nbsp;which is a portal for viral entrance to the body.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-mudgal-135">[133]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-rhee-136">[134]</a></sup>&nbsp;These vaccines are designed to stimulate nasal&nbsp;<a href="https://en.wikipedia.org/wiki/Immune_factor">immune factors</a>, such as&nbsp;<a href="https://en.wikipedia.org/wiki/Immunoglobulin_A">IgA</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-mudgal-135">[133]</a></sup>&nbsp;In addition to inhibiting the virus, nasal vaccines provide ease of administration because no needles (and the accompanying&nbsp;<a href="https://en.wikipedia.org/wiki/Fear_of_needles">needle phobia</a>) are involved.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-rhee-136">[134]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-cdc-137">[135]</a></sup>&nbsp;Nasal vaccines have been approved for&nbsp;<a href="https://en.wikipedia.org/wiki/Influenza">influenza</a>,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-rhee-136">[134]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-cdc-137">[135]</a></sup>&nbsp;but not for COVID-19.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>There are a variety of intranasal COVID-19 vaccines undergoing clinical trials. Examples include a vaccine candidate which uses a modified avian virus as a vector to target SARS-CoV-2 spike proteins and an mRNA vaccine delivered via a nasal nanoparticle spray.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-138">[136]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":4} -->
<h4>Autologous</h4>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Aivita Biomedical is developing an experimental autologous&nbsp;<a href="https://en.wikipedia.org/wiki/Dendritic_cell">dendritic cell</a>&nbsp;COVID‑-19 vaccine kit where the vaccine is prepared and incubated at the point-of-care using cells from the intended recipient.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Nistor_2022-139">[137]</a></sup>&nbsp;The vaccine is undergoing small phase I and phase II clinical studies.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Nistor_2022-139">[137]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-140">[138]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-141">[139]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading {"level":4} -->
<h4>Universal</h4>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/Universal_coronavirus_vaccine">Universal coronavirus vaccine</a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>A universal coronavirus vaccine is effective against all coronavirus (and possibly other) viruses.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-142">[140]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:02-143">[141]</a></sup>&nbsp;The concept was publicly endorsed by&nbsp;<a href="https://en.wikipedia.org/wiki/NIAID">NIAID</a>&nbsp;director&nbsp;<a href="https://en.wikipedia.org/wiki/Anthony_Fauci">Anthony Fauci</a>,&nbsp;<a href="https://en.wikipedia.org/wiki/Virology">virologist</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Jeffery_Taubenberger">Jeffery K. Taubenberger</a>, and David M. Morens.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-:32-144">[142]</a></sup>&nbsp;In March 2022, the&nbsp;<a href="https://en.wikipedia.org/wiki/White_House">White House</a>&nbsp;released the "National COVID-19 Preparedness Plan", which recommended to accelerate development of such vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-145">[143]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>One strategy for developing such vaccines was developed at&nbsp;<a href="https://en.wikipedia.org/wiki/Walter_Reed_Army_Institute_of_Research">Walter Reed Army Institute of Research</a>&nbsp;(WRAIR). It uses a spike ferritin-based nanoparticle (SpFN). This vaccine began a Phase I clinical trial in April 2022.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-146">[144]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Another strategy is to attach vaccine fragments from multiple strains to a&nbsp;<a href="https://en.wikipedia.org/wiki/Nanoparticle">nanoparticle</a>&nbsp;scaffold. Universality is enhanced by targeting the receptor-binding domain rather than the&nbsp;<a href="https://en.wikipedia.org/wiki/Spike_protein">spike protein</a>.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-147">[145]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:heading -->
<h2>Planning and development</h2>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>Main article:&nbsp;<a href="https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_development">History of COVID-19 vaccine development</a></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Since January 2020, vaccine development has been expedited via unprecedented collaboration in the&nbsp;<a href="https://en.wikipedia.org/wiki/Pharmaceutical_industry">multinational pharmaceutical industry</a>&nbsp;and between governments.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh22-44">[43]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Multiple steps along the entire development path are evaluated, including:<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-gates2-26">[25]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-simpson-148">[146]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:list -->
<ul><li>the level of acceptable toxicity of the vaccine (its safety),</li><li>targeting vulnerable populations,</li><li>the need for vaccine efficacy breakthroughs,</li><li>the duration of vaccination protection,</li><li>special delivery systems (such as oral or nasal, rather than by injection),</li><li>dose regimen,</li><li>stability and storage characteristics,</li><li>emergency use authorization before formal licensing,</li><li>optimal manufacturing for scaling to billions of doses, and</li><li>dissemination of the licensed vaccine.</li></ul>
<!-- /wp:list -->

<!-- wp:heading {"level":3} -->
<h3>Challenges</h3>
<!-- /wp:heading -->

<!-- wp:paragraph -->
<p>There have been several unique challenges with COVID‑19 vaccine development.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The urgency to create a vaccine for COVID‑19 led to compressed schedules that shortened the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over several years.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-sanger-149">[147]</a></sup>&nbsp;Public health programs have been described as in "[a] race to vaccinate individuals" with the early wave vaccines.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-150">[148]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Timelines for conducting clinical research&nbsp;– normally a sequential process requiring years&nbsp;– are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-sanger-149">[147]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-reuters-151">[149]</a></sup>&nbsp;As an example, Chinese vaccine developers and the government&nbsp;<a href="https://en.wikipedia.org/wiki/Chinese_Center_for_Disease_Control_and_Prevention">Chinese Center for Disease Control and Prevention</a>&nbsp;began their efforts in January 2020,<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-152">[150]</a></sup>&nbsp;and by March were pursuing numerous candidates on short timelines, with the goal to showcase Chinese technology strengths over those of the United States, and to reassure the Chinese people about the quality of vaccines produced in China.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-sanger-149">[147]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-wee-153">[151]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The rapid development and urgency of producing a vaccine for the COVID‑19 pandemic was expected to increase the risks and failure rate of delivering a safe, effective vaccine.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-thanh-76">[74]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-diamond-77">[75]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Thorp-154">[152]</a></sup>&nbsp;Additionally, research at universities is obstructed by&nbsp;<a href="https://en.wikipedia.org/wiki/Social_distancing">physical distancing</a>&nbsp;and closing of laboratories.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-155">[153]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-156">[154]</a></sup></p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>Vaccines must progress through several phases of <a href="https://en.wikipedia.org/wiki/Clinical_trial">clinical trials</a> to test for safety, <a href="https://en.wikipedia.org/wiki/Immunogenicity">immunogenicity</a>, effectiveness, dose levels and <a href="https://en.wikipedia.org/wiki/Vaccine_adverse_event">adverse effects</a> of the candidate vaccine.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-Vaccines.gov-157">[155]</a></sup><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-fda-ddp-158">[156]</a></sup> Vaccine developers have to invest resources internationally to find enough participants for Phase II–III clinical trials when the virus has proved to be a "<a href="https://en.wikipedia.org/wiki/Moving_target_indication">moving target</a>" of changing transmission rates across and within countries, forcing companies to compete for trial participants.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-cohen6-19-159">[157]</a></sup> Clinical trial organizers also may encounter people unwilling to be vaccinated due to <a href="https://en.wikipedia.org/wiki/Vaccine_hesitancy">vaccine hesitancy</a><sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-dube-160">[158]</a></sup> or disbelief in the science of the vaccine technology and its ability to prevent infection.<sup><a href="https://en.wikipedia.org/wiki/COVID-19_vaccine#cite_note-howard-cnn-161">[159]</a></sup> As new vaccines are developed during the COVID‑19 pandemic.</p>
<!-- /wp:paragraph -->
